Data / Form D filings / Addex Therapeutics Ltd.
Addex Therapeutics Ltd.: Form D filings
Addex Therapeutics Ltd., a biotechnology company in Geneva, Switzerland, filed 3 Form D notices with the SEC between 2021 and 2023. The latest, on April 13, 2023, reports $3.7 million sold of a $3.7 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- CHEMIN DES MINES 9, Geneva, Switzerland, CH-12
- Phone
- 01141228841555
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Switzerland
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1574232
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 13, 2023 | New notice | $3,733,334 | $3,733,334 | 1 | Apr 5, 2023 | sec.gov | |
| Aug 4, 2022 | New notice | $4,230,500 | $4,230,500 | 1 | Jul 22, 2022 | sec.gov | |
| Dec 21, 2021 | New notice | $5,935,118 | $5,935,118 | 1 | Dec 21, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jean-Philippe Rocher | Executive Officer | |
| Vincent Lawton | Director | |
| Mikhail Kalinichev | Executive Officer | |
| Jake Nunn | Director | |
| Timothy Dyer | Executive Officer, Director | |
| Isaac Manke | Director | |
| Robert Lutjens | Executive Officer | |
| Raymond Hill | Director | |
| Roger Mills | Executive Officer, Director |
Every Form D from the week of Apr 10, 2023 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Addex Therapeutics Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.